Evidence map›Paper›PMID 29980663›Full record

ArticleNature communications2018

Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa.

Laura Bricio-Moreno, Victoria H Sheridan, Ian Goodhead, Stuart Armstrong, Janet K L Wong, Elaine M Waters, Joscelyn Sarsby, Stavros Panagiotou, James Dunn, Adrita Chakraborty and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. The influence ofMicrobiology (Reading, England) · 2025
    Article
  4. Induction of lipid A modification genes inJournal of medical microbiology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. RclS Sensor Kinase Modulates Virulence ofInternational journal of molecular sciences · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Antibiotic Resistance in Pseudomonas.Advances in experimental medicine and biology · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Laura Bricio-MorenoInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Victoria H SheridanInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Ian GoodheadSchool of Environment and Life Sciences, University of Salford, Salford, M5 4WT, UK.
Stuart ArmstrongInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Janet K L WongInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Elaine M WatersInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Joscelyn SarsbyInstitute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK.
Stavros PanagiotouInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
James DunnInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Adrita ChakrabortyInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Yongliang FangThayer School of Engineering, Dartmouth, Hanover, NH, 03755, USA.
Karl E GriswoldThayer School of Engineering, Dartmouth, Hanover, NH, 03755, USA.ORCID http://orcid.org/0000-0002-9835-3394
Craig WinstanleyInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Joanne L FothergillInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK. j.fothergill@liverpool.ac.uk.
Aras KadiogluInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK.
Daniel R NeillInstitute of Infection and Global Health, University of Liverpool, Liverpool, L69 7BE, UK. d.neill@liverpool.ac.uk.ORCID http://orcid.org/0000-0002-7911-8153
University of Liverpool · GBDartmouth College · USUniversity of Salford · GB

Funding

Understanding the role of RNA-binding protein mutations in cancerP20GM113132 · NIGMS · DARTMOUTH COLLEGE · PI MADDEN, DEAN R · 2016 to 2025
$25.9M
Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, Lucas R Hoffman · 2010 to 2026
$21.4M
MRF_ MRF-091-0006-RG-FOTHENIDDK NIH HHS P30 DK089507NIGMS NIH HHS P20 GM113132Wellcome Trust
6 · The paper itself

Abstract

Pseudomonas aeruginosa colonises the upper airway of cystic fibrosis (CF) patients, providing a reservoir of host-adapted genotypes that subsequently establish chronic lung infection. We previously experimentally-evolved P. aeruginosa in a murine model of respiratory tract infection and observed early-acquired mutations in pmrB, encoding the sensor kinase of a two-component system that promoted establishment and persistence of infection. Here, using proteomics, we show downregulation of proteins involved in LPS biosynthesis, antimicrobial resistance and phenazine production in pmrB mutants, and upregulation of proteins involved in adherence, lysozyme resistance and inhibition of the chloride ion channel CFTR, relative to wild-type strain LESB65. Accordingly, pmrB mutants are susceptible to antibiotic treatment but show enhanced adherence to airway epithelial cells, resistance to lysozyme treatment, and downregulate host CFTR expression. We propose that P. aeruginosa pmrB mutations in CF patients are subject to an evolutionary trade-off, leading to enhanced colonisation potential, CFTR inhibition, and resistance to host defences, but also to increased susceptibility to antibiotics.

Indexed as

Adaptation, PhysiologicalBiological EvolutionHost-Pathogen InteractionsA549 CellsAnimalsAnti-Infective AgentsBacterial AdhesionBacterial ProteinsColony Count, MicrobialCystic Fibrosis Transmembrane Conductance RegulatorDown-RegulationEpithelial CellsFimbriae, BacterialHumansLungMiceAnti-Infective AgentsBacterial ProteinsCystic Fibrosis Transmembrane Conductance RegulatorMuramidasePmrB protein, bacteriaTranscription Factors

Identifiers

PMID29980663
PMCPMC6035264
OpenAlexW2806074028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.